App
X

Suven Pharmaceuticals Ltd - Stock Price

As on27 Jun 2022
  • NSE : SUVENPHAR
  • BSE : 543064
  • ISIN CODE : INE03QK01018
  • Industry : Pharmaceuticals & Drugs
  • House : Private
Suven Pharmaceuticals Ltd is not traded on BSE/NSE
470.45
-1.21 %-5.75
Previous Close 476.20
Day's Open 479.50
Bid Price (Qty) 0.00 (0)
Offer Price (Qty) 470.45 (294)
Day’s High - Low 483.20 - 465.05
52 Week Range 425.7 - 631.75
Volume Traded (in 000's) 66.64
Value traded (in Cr.) 3.16
PE Ratio (x) 21.51
M Cap (in Cr.)12006.56

Suven Pharmaceuticals Ltd Stock Price

03/02/2017 | 15:19
  • Current Price8741.20
  • Open8735.15
  • High8748.25
  • Low8707.75
  • Prev. Close8734.25

Fundamentals

Parameter Values
Market Cap (Rs. in Cr.) 12006.56
Earning Per Share (EPS TTM) (Rs.) 21.92
Price To Earnings (P/E) Ratio 21.51
Book Value Per Share (Rs.) 59.74
Price/Book (MRQ) 7.90
Price/Earning (TTM) 20.10
ROCE (%) 39.15
PAT Margin 30.57
Dividend Yield 0.64
Face Value 1

Financial Summary

Parameter MAR 21 (`Mn.) MAR 20 (`Mn.) YoY %Change
Balance Sheet :
Share Capital254.57127.28100.00
Total Non-Current Liabilities739.091276.76-42.11
Total Current Liabilities3215.063198.460.52
Total Liabilities15762.2312922.8521.97
Total Non-Current Assets9096.807811.6716.45
Currents Investments1805.94306.73488.77
Cash and Bank96.53140.75-31.42
Total Current Assets6665.435111.1830.41
Total Assets15762.2312922.8521.97
Profit & Loss :
Gross Sales10097.208337.9021.10
Net Sales10097.208337.9021.10
Total Expenditure5667.204490.3026.21
Operating Profit4572.404028.7013.50
Profit After Tax3086.102687.9014.81
More from Financial Summary »

held by Mutual Fund Schemes

Scheme Holding(%)  
More from Held By MF Schemes »

News & Updates

Peer Comparison

More Comparison »

Share Holdings

Description Percent of Share (%)
Promoters60
Non-Institution24.88
Mutual Funds/Uti5.91
Fi/Banks/Insurance0
Government0
FII0
More from Share holdings »

Corporate Information

Management Info

  • Chairman: Venkateswarlu Jasti
  • Managing Director: Venkateswarlu Jasti
  • Secretary: K Hanumantha Rao

Registered Office

Address : #8-2-334 I, S D E Serene Chambers,6th Floor Road No. 5,Avenue 7, Banjara Hills, Hyderabad,
Telangana-500034 Tel : 040 - 2354 9414/ 3311/ 3315 Fax : 040 - 2354 1152 Email : info@suvenpharm.com Website : www.suvenpharm.com

Registars Details

K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.)
Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad

About Suven Pharmaceuticals Ltd.

Suven Pharmaceuticals Ltd. was incorporated in the year 2018. Its today's share price is 471.65. Its current market capitalisation stands at Rs 12006.56 Cr. In the latest quarter, company has reported Gross Sales of Rs. 10097.19 Cr and Total Income of Rs.10239.56 Cr. The company's management includes K Hanumantha Rao, Jerry Jeyasingh, JV Ramudu, Deepanwita Chattopadhyay, DG Prasad, Venkateswarlu Jasti, Venkateswarlu Jasti.

It is listed on the BSE with a BSE Code of 543064 , NSE with an NSE Symbol of SUVENPHAR and ISIN of INE03QK01018. It's Registered office is at #8-2-334 I, S D E Serene Chambers,6th Floor Road No. 5,Avenue 7, Banjara Hills Hyderabad-500034, Telangana. Their Registrars are K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.) It's auditors are Karvy & Co, Tukaram & Co LLP

Latest News

close